Viking Therapeutics, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2014 | $0 | $-209.7K | $-228.9K |
| Jun 2014 | $0 | $-21.8M | $-22.8M |
| Sep 2014 | $0 | $-1.1M | $-261.8K |
| Dec 2014 | $0 | $-353.6K | $1.4M |
| Mar 2015 | $0 | $-461.0K | $-5.7M |
| Jun 2015 | $0 | $-2.6M | $-7.9M |
| Sep 2015 | $0 | $-4.3M | $-4.7M |
| Dec 2015 | $0 | $-4.6M | $-5.1M |
| Mar 2016 | $0 | $-3.3M | $-3.6M |
| Jun 2016 | $0 | $-3.6M | $-3.7M |
| Sep 2016 | $0 | $-3.3M | $-3.8M |
| Dec 2016 | $0 | $-3.7M | $-3.6M |
| Mar 2017 | $0 | $-5.0M | $-5.2M |
| Jun 2017 | $0 | $-5.0M | $-5.2M |
| Sep 2017 | $0 | $-4.7M | $-6.1M |
| Dec 2017 | $0 | $-4.4M | $-4.1M |
| Mar 2018 | $0 | $-4.8M | $-3.6M |
| Jun 2018 | $0 | $-6.9M | $-6.7M |
| Sep 2018 | $0 | $-7.4M | $-6.6M |
| Dec 2018 | $0 | $-7.0M | $-5.2M |
| Mar 2019 | $0 | $-6.8M | $-4.9M |
| Jun 2019 | $0 | $-9.6M | $-7.7M |
| Sep 2019 | $0 | $-7.4M | $-5.7M |
| Dec 2019 | $0 | $-8.9M | $-7.5M |
| Mar 2020 | $0 | $-10.9M | $-9.7M |
| Jun 2020 | $0 | $-10.6M | $-9.6M |
| Sep 2020 | $0 | $-9.8M | $-9.3M |
| Dec 2020 | $0 | $-11.3M | $-10.9M |
| Mar 2021 | $0 | $-14.2M | $-14.0M |
| Jun 2021 | $0 | $-15.5M | $-15.4M |
| Sep 2021 | $0 | $-13.4M | $-13.2M |
| Dec 2021 | $0 | $-12.5M | $-12.4M |
| Mar 2022 | $0 | $-16.2M | $-16.1M |
| Jun 2022 | $0 | $-17.6M | $-17.4M |
| Sep 2022 | $0 | $-16.2M | $-15.8M |
| Dec 2022 | $0 | $-20.3M | $-19.6M |
| Mar 2023 | $0 | $-20.5M | $-19.5M |
| Jun 2023 | $0 | $-23.7M | $-19.2M |
| Sep 2023 | $0 | $-27.3M | $-22.5M |
| Dec 2023 | $0 | $-29.3M | $-24.6M |
| Mar 2024 | $0 | $-34.1M | $-27.4M |
| Jun 2024 | $0 | $-34.1M | $-22.3M |
| Sep 2024 | $0 | $-36.6M | $-24.9M |
| Dec 2024 | $0 | $-46.2M | $-35.4M |
| Mar 2025 | $0 | $-55.5M | $-45.6M |
| Jun 2025 | $0 | $-74.6M | $-65.6M |
| Sep 2025 | $0 | $-98.6M | $-90.8M |
| Dec 2025 | $0 | $-164.7M | $-157.7M |
| Mar 2026 | $0 | $-164.1M | $-158.3M |
| Jun 2026 | $0 | $-132.6M | $-128.0M |